A group of local investors and a Canadian-based, New Zealand academic, have contributed half a million dollars to carry out a clinical trial, with more to come as the vaccine progresses.
It will cost about $8 million to get a vaccine to market.
Jeff Douglas, the managing director of Douglas Pharmaceuticals, will chair the company Covid-19 Vaccine Corporation…
TO READ FULL STORY Clik Here!
from : www.odt.co.nz